| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Silver Brian M. serves as a Chief Financial Officer at TCRX. Across recent SEC filings that breaks down to 6 buys and 0 sells. Those positions are worth an estimated $51K at current prices.
Historically, Silver Brian M.'s trades have earned a below-average insider score of 40/100 across 6 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -1.7%.
The biggest single holding is TCRX (~$51K) as Chief Financial Officer. Net of sales, the recent Form 4 record there shows accumulation of 32,885 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 28, 2022 | TCRX Tscan Therapeutics, Inc. | Chief Financial Officer | Buy | 6,000 | $1.54 | $9,217.36 | +22.3% | +62.4% | +280.9% | |
| Mar 24, 2022 | TCRX Tscan Therapeutics, Inc. | Chief Financial Officer | Buy | 15,000 | $3.40 | $50,982.00 | +126.2% | -6.6% | -27.5% | |
| Sep 21, 2021 | TCRX Tscan Therapeutics, Inc. | Chief Financial Officer | Buy | 5,000 | $6.32 | $31,585.00 | +72.6% | -29.6% | -55.0% | |
| Sep 9, 2021 | TCRX Tscan Therapeutics, Inc. | Chief Financial Officer | Buy | 5,885 | $8.48 | $49,925.40 | +588.5% | -24.5% | -60.5% | |
| Jul 20, 2021 | TCRX Tscan Therapeutics, Inc. | Chief Financial Officer | Buy | 1,000 | $15.00 | $15,000.00 | New | -38.4% | -66.9% |